Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania's economy delivered a mild upside surprise in the third quarter, with flash estimates pointing to 1.6% annual growth, above expectations. However, the economy still contracted by 0.2% versus the previous quarter. After nine months of 2025, the economy is 0.8% above the same period of 2024, according to a report by ING Bank Romania.
MedLife, Romania's largest private healthcare network, announced financial results for the first nine months of 2025. The group recorded consolidated pro-forma revenue of over RON 2.36 billion (€464 million), up 19.5% compared to the same period in 2024. EBITDA pro-forma increased by 20.4% compared to the first nine months of last year.
The Romanian Investment and Development Bank (BID) has committed €20 million to the Three Seas Initiative Innovation Fund, becoming the fifth national promotional institution to support the EIF-led investment vehicle targeting growth-stage companies across Central and Eastern Europe.
Digi Communications has announced its Q3 2025 financial results, showing consolidated revenues of €561 million, up 14% compared to the same period last year. The telecom company achieved total revenues of €1.643 billion for the first nine months of 2025, representing a 16% increase year-on-year.
BT and BT Investments have received approval from the Financial Supervisory Authority to acquire BRD Pensii and the BRD mandatory private pension fund (pillar 2).